The PennZone

PHILADELPHIA, Oct. 22, 2024 ~ A recent study conducted by researchers at Children's Hospital of Philadelphia (CHOP) has shown the potential for rapid testing of cytokine levels to aid in distinguishing between different diseases with similar symptoms. The findings, published in the Journal of Allergy and Clinical Immunology, demonstrate the impact this testing can have on clinical practice.

The study, led by Dr. Michele P. Lambert, Medical Director of the Special Coagulation Laboratory and attending physician in the Division of Hematology at CHOP, focused on the use of serum cytokine panels in pediatric clinical practice. Cytokines are signaling proteins that regulate inflammation and coordinate immune responses.

During the COVID-19 pandemic, doctors faced a challenge in distinguishing between multisystem inflammatory syndrome in children (MIS-C) and acute, severe COVID-19 infection. Both conditions present with similar initial symptoms such as high fever and changes in blood pressure, but require very different courses of treatment.

Dr. Lambert explains, "We wanted to see what clinicians were able to do with this information if it was returned rapidly and whether results would change clinical decision making or muddy the waters and create confusion."

More on The PennZone

• $620 Million in Recent Government Contract Awards with More Than $1.2 Billion in Annualized Revenue: Circle8 Group (N A S D A Q: CIRC)
• Lewis County Hydrogen Alliance Launches Phase 1 Work to Turn Forest Residuals into Fuel-Grade Hydrogen and Dispatchable Clean Power
• Next Gen Fibre Selects netElastic vBNG and CGNAT to Fuel Rapid Nationwide Expansion and Eliminate Network Bottlenecks
• Boston Industrial Solutions, Inc. Introduces SAP-G70 Primer for bonding silicone to silicone and other materials
• 'Reflections: Enlightening Insights Into the Divine Mystery' — The Latest Book by Philosopher Steven Colborne

The study found that nearly 30% of clinicians changed how they managed disease in children after receiving cytokine level information. In 18.8% of cases, the diagnosis was changed or informed by the results, while management of the patient was changed or informed in 29.8% of cases.

One key finding was that specific disease states had clear cytokine patterns. For example, higher levels of interferon gamma (IFNg) and lower levels of interleukins 6 and 8 (IL-6 and IL-8) suggested a more robust inflammatory response, while a reverse in those levels indicated bacterial or viral sepsis.

Dr. Lambert emphasizes the potential life-saving impact of these results: "The results of a cytokine panel could potentially save lives: supporting antibiotics or immune suppression, but only if we have the results fast enough."

The study also highlights the importance of collaboration between clinicians and clinical laboratories in providing the best care for patients. As Dr. Lambert notes, "The evolution of our response time and our understanding of the value of these biomarkers demonstrates how important it is for clinicians and clinical laboratories to collaborate to provide the best care possible for patients."

With ongoing advancements in technology and understanding, rapid testing of cytokine levels has the potential to greatly impact clinical practice and improve patient outcomes. The study, titled "Serum Cytokine Panels in Pediatric Clinical Practice," was published online on September 18, 2024, with a DOI of 10.1016/j.jaci.2024.08.030.

For further information or inquiries, please contact Amanda DiPaolo Bradley at [insert contact information].

---

Show All News | Disclaimer | Report Violation